GW-501516 is a premium research compound and PPARδ receptor agonist currently under trial as a cardiovascular and improved physical output and performance product. GW-501516 has gained much attention in the performance enhancement world and for good reason due to its highly effective performance capabilities...
SR-9009 is a brand-new performance compound discovered to yield drastically improved performance capabilities in subjects leading to enhanced cardiovascular output and a steady state of exercise leading to improved performance and output that has been well documented. It is known as an agonist of Rev-ErbA and increases exercise capacity in subjects specifically by increasing mitochondria in skeletal muscle.